Increased cardiovascular reactivity in renal infarction hypertension.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D006977:Hypertension, Renal / Q000139:chemically induced; D007238:Infarction; D007674:Kidney Diseases; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D011311:Pressoreceptors / Q000187:drug effects*; D051381:Rats; D012083:Renin / Q000494:pharmacology; D013997:Time Factors; D014439:Tyramine / Q000494:pharmacology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D012083:Renin; D009638:Norepinephrine; D014439:Tyramine